brands under fire
Posted by Abe Sauer on October 10, 2013 12:55 PM
It's been three weeks since investigative journalists at ProPublica published a long profile of the severe potential danger in overusing the pain reliever acetaminophen. The report's most damaging allegations were not that 150 people a year die from acetaminophen but that safety agencies and manufacturers—especially household acetaminophen brand Tylenol—knew how dangerous the drug was and did little to warm users.
ProPublica's several stories, which make claims like, "[Tylenol maker] McNeil opposed even a modest government campaign to educate the public about acetaminophen’s risks, in part because it would harm Tylenol sales," are pretty damning for the brand, but the government agencies that oversee such operations don't make it out unscathed either. "Over more than 30 years, the FDA has delayed or failed to adopt measures designed to reduce deaths and injuries from acetaminophen. The agency began a comprehensive review to set safety rules for acetaminophen in the 1970s, but still has not finished," another report says.Continue reading...
Posted by Dale Buss on September 11, 2013 09:19 AM
Apple gets license to run phones on China Mobile network.
Aramark files for $100 million IPO.
Target launches digital movie and TV service.
BMW fights SUV lead by Mercedes-Benz with new "Boss" version of X5.
Best Buy CEO sells shares to help pay for his divorce.
Four Seasons Hotels starts a food truck.
GM sees Canada sell part of its stake in automaker and perceives opportunity in Europe to push Chevy as value brand.
Gevalia launches frothy K-cups.
Google Play gets a new logo.
Home Depot is accused of shaking down suspected shoplifters.
Intel unveils line of chips for wearable devices.
J&J reintroduces Tylenol.Continue reading...
Posted by Dale Buss on September 4, 2013 09:14 AM
Kodak officially ends bankruptcy.
Petco launches transformation effort.
Toyota announces hybrids recall.
Amazon unveils new Kindle, Matchbook service.
Bank of America exits China bank stake.
Bison Council pushes acceptance of the meat.
Chick-fil-A offers free breakfast, with reservation.
Chrysler posts 12 percent sales gain in August as all brands ready for US sales reports today.
Google partners with Nestle to name new operating system.
Hershey boosts ad spending and sales have followed.
Johnson & Johnson adds red warning label on Tylenol over dosage concerns.
JCPenney finds love from other hedge funds.Continue reading...
Posted by Mark J. Miller on May 7, 2013 11:40 AM
It hasn’t been a great couple of years for Johnson & Johnson. Since 2009, “faulty manufacturing” caused J&J to “recall millions of bottles and packages of Tylenol, Benadryl, Motrin and other over-the-counter medicines,” NBC News reports. While that was happening, pharmacies were starting to push their own private labels.
It got so bad that this past winter, CVS didn’t even stock Tylenol at a number of its stores. That isn't all. The company is facing over 10,000 lawsuits regarding the alleged failure of its Depuy metal-on-metal hip transplants, and it just got done paying $181 million in settlements over off-label marketing of its antipsychotic drug, Risperdal, Ad Age notes.
As Mad Men’s Don Draper says, if you don’t like what people are saying, you change the conversation. So J&J is going all-in on a rebrand, putting up to $30 million into a play-to-the-heartstrings Band-Aid of a campaign called “For All You Love.”Continue reading...
Posted by Shirley Brady on October 2, 2012 08:45 AM
Interbrand's 2012 Best Global Brands report sees Coca-Cola on top, Apple and Samsung make gains, Disney and HP decline, and BlackBerry lose 39 percent of brand value.
Samsung files to add iPhone 5 to Apple patent lawsuit as US court lifts injunction against Galaxy Tab sales and Galaxy S3 outsells iPhone 5 in UK.
Amazon plans to hire 10,000 British temp employees for the holidays.
American Airlines accuses pilots of sabotage as loose seats embarrass execs.
American Express ordered to refund $85 million to customers and pay $27.5 million in penalties.
Apple's iPad Mini rumored for Oct. 17 unveiling.
Cadbury wins exclusive right to its signature purple color in legal battle.
Disney unveils new homepage with entertainment focus.
Facebook sells more access to members as part of ad analytics push; Wall Street approves.
Google's stock market value passes Microsoft's for the first time.
Guinness launches "cloud TV" campaign.Continue reading...
Posted by Shirley Brady on November 22, 2011 08:55 AM
AIG's former CEO, Hank Greenberg, sues U.S. government and Federal Reserve Bank for $25 billion over takeover.
Bill Gates testifies in Novell suit vs. Microsoft.
Cadbury's trademarks its distinctive shade of purple.
David Beckham's legacy starts to be assessed as Los Angeles Galaxy ending looms and Paris beckons.
Donald Trump estimates the Trump name's worth at $3 billion.
eBay buys Hunch to help discern individuals' taste.
GE expands to Iraq.
GM retools former Saturn site and prepares to manufacture China autos in Egypt.
HP reports spending $3.3 billion on WebOS as Meg Whitman sets course for turnaround.Continue reading...
Posted by Dale Buss on August 1, 2011 09:00 AM
Markets rally as Sunday night's U.S. debt limit deal goes before Congress for a vote today as Twitter explodes over deal.
Airbnb investor suggests ransacked woman is lying.
Al Jazeera English launches in New York.
Ambassador Coffee brand changes hands.
Apple wins dispute over iPods.com domain.
Bank of America hit with new Countrywide lawsuit.
Bloomberg Businessweek to hike paid circulation.Continue reading...
Posted by Barry Silverstein on March 8, 2011 05:30 PM
We may be witnessing a slowly developing economic recovery, but that's little consolation to the pharmaceutical industry. This year, according to the New York Times, drug companies will see annual sales of almost $50 billion evaporate. Why? Because the patents for more than 10 major drug brands will expire.
It's a reality that has lingered for years. A drug company invests huge amounts of money in R&D and finally wins approval to bring a drug to market under a brand name.
But that drug can only be protected by a patent for a certain number of years; when the patent expires, generic versions of the drug can be sold, almost always at a cheaper price. Take Tylenol, for example, one of the brand names for acetaminophen. Continue reading...